share_log

MiNK Therapeutics | 8-K: MiNK Reports Fourth Quarter and Year-End 2023 Results

SEC announcement ·  Mar 21 07:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more